Understanding how MSC extracellular vesicles help brain recovery after injury
Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery
This study is looking at how tiny particles from special cells can help brain cells recover and work better after a brain injury, with the hope of finding new ways to support healing and protect the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10719905 on NIH RePORTER |
What this research studies
This research investigates how extracellular vesicles from mesenchymal stromal cells (MSCs) can influence the metabolism and energy production of microglia, which are crucial for brain recovery following traumatic brain injury (TBI). The study aims to identify new strategies to modulate the immune response in the brain, focusing on the role of these vesicles in protecting the blood-brain barrier and promoting a healing environment. By examining the interactions between MSC-EVs and microglia, the research seeks to develop innovative therapies that could enhance recovery from TBI.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced a traumatic brain injury and are seeking innovative therapeutic options.
Not a fit: Patients with non-traumatic brain injuries or those who do not have significant neuroinflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery outcomes for patients with traumatic brain injuries.
How similar studies have performed: Previous research has shown promise in using MSC-derived extracellular vesicles for various therapeutic applications, indicating potential success for this novel approach in TBI recovery.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: West, Franklin D — University of Georgia
- Study coordinator: West, Franklin D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.